updating data for batch codes

docs/SymptomsCausedByDrugs/data/ProportionalReportingRatios/vaccines/1260.json

@@ -1 +1 @@
-{"adverse drug reaction": 6.03, "adverse event": 2.18, "ageusia": 2.28, "alanine aminotransferase increased": 4.32, "amylase increased": 2.39, "ascites": 2.15, "aspartate aminotransferase increased": 4.4, "blood albumin decreased": 2.38, "blood alkaline phosphatase increased": 2.48, "blood bilirubin increased": 7.9, "blood pressure increased": 3.21, "blood sodium decreased": 2.42, "blood thyroid stimulating hormone increased": 9.16, "blood urine present": 3.24, "bone cancer": 2.77, "brain neoplasm": 5.34, "cardiac failure": 2.5, "cardiotoxicity": 5.62, "clear cell renal cell carcinoma": 29.64, "death": 10.81, "decreased appetite": 3.8, "dehydration": 2.82, "diarrhoea": 3.53, "disease progression": 8.7, "dry skin": 2.21, "ejection fraction decreased": 10.16, "gastric haemorrhage": 2.02, "gastrointestinal perforation": 6.42, "haemoptysis": 3.79, "hair colour changes": 92.55, "hepatic cytolysis": 3.33, "hepatic enzyme increased": 7.51, "hepatic failure": 4.28, "hepatic function abnormal": 2.41, "hepatitis": 2.17, "hepatotoxicity": 15.51, "hip surgery": 6.64, "hospice care": 69.8, "hospitalisation": 9.33, "hyperbilirubinaemia": 5.24, "hyperkeratosis": 4.65, "hypertension": 5.33, "hypertensive crisis": 4.11, "hypertransaminasaemia": 8.44, "hypothyroidism": 4.71, "ill-defined disorder": 3.04, "impaired healing": 4.0, "intestinal perforation": 8.72, "jaundice": 4.49, "large intestine perforation": 5.24, "left ventricular dysfunction": 2.74, "lipase increased": 2.39, "liver disorder": 2.15, "liver function test abnormal": 2.95, "liver function test increased": 8.53, "liver injury": 2.15, "maligt neoplasm progression": 13.07, "metastases to bone": 7.55, "metastases to central nervous system": 13.37, "metastases to liver": 7.18, "metastases to lung": 25.66, "metastases to lymph nodes": 6.52, "metastases to spine": 9.91, "metastasis": 17.16, "metastatic neoplasm": 9.98, "metastatic renal cell carcinoma": 38.18, "mucosal inflammation": 6.28, "neoplasm": 4.53, "neoplasm progression": 2.04, "nephrotic syndrome": 4.23, "oral pain": 2.08, "palmar-plantar erythrodysaesthesia syndrome": 8.65, "pancreatitis": 2.09, "pigmentation disorder": 3.01, "pleural effusion": 3.56, "pneumothorax": 22.93, "posterior reversible encephalopathy syndrome": 10.69, "product use in unapproved indication": 3.07, "proteinuria": 6.71, "pulmonary haemorrhage": 2.22, "pulmonary mass": 4.27, "pulmonary thrombosis": 2.02, "radiotherapy": 19.2, "renal cancer": 2.57, "renal cancer metastatic": 66.29, "renal cell carcinoma": 23.68, "renal cell carcinoma stage iv": 75.48, "renal surgery": 58.92, "retinal detachment": 4.03, "retinal tear": 6.67, "sarcoma": 54.89, "sarcoma metastatic": 217.19, "second primary maligcy": 4.63, "skin discolouration": 2.85, "skin toxicity": 4.21, "skin ulcer": 2.59, "soft tissue sarcoma": 345.42, "stomatitis": 4.1, "surgery": 3.04, "taste disorder": 5.22, "transaminases increased": 5.09, "tumour excision": 35.48, "tumour haemorrhage": 7.53, "tumour pain": 29.65, "weight decreased": 3.09, "wound": 2.11, "yellow skin": 3.82}
+{"abdominal distension": 2.7, "amyloidosis": 153.93, "ascites": 2.23, "atrial fibrillation": 8.42, "atrial flutter": 15.6, "atrioventricular block complete": 11.65, "balance disorder": 2.34, "bradycardia": 2.95, "brain natriuretic peptide increased": 30.16, "cardiac amyloidosis": 736.74, "cardiac disorder": 4.74, "cardiac failure": 26.39, "cardiac failure chronic": 315.91, "cardiac failure congestive": 3.32, "cardiomyopathy": 11.52, "carpal tunnel syndrome": 11.56, "cerebral infarction": 2.22, "cognitive disorder": 2.18, "condition aggravated": 4.92, "constipation": 2.07, "death": 2.67, "dementia": 5.74, "diastolic dysfunction": 38.13, "disease progression": 9.38, "disease recurrence": 2.31, "dysphagia": 4.75, "dyspnoea exertional": 5.13, "ejection fraction decreased": 9.19, "fall": 3.57, "flatulence": 4.27, "fluid retention": 5.78, "gait disturbance": 2.08, "gait inability": 2.47, "gamma-glutamyltransferase increased": 3.53, "gastrointestinal disorder": 2.17, "general physical health deterioration": 2.86, "glomerular filtration rate decreased": 6.11, "gout": 7.14, "hereditary neuropathic amyloidosis": 4041.79, "hypervolaemia": 8.24, "hypoacusis": 2.39, "intentional product misuse": 3.06, "left ventricular dysfunction": 13.02, "left ventricular hypertrophy": 81.15, "loss of personal independence in daily activities": 2.8, "mitral valve incompetence": 17.3, "n-terminal prohormone brain natriuretic peptide increased": 56.79, "neuropathy peripheral": 2.84, "oedema": 2.93, "oedema peripheral": 3.29, "off label use": 3.54, "orthostatic hypotension": 7.12, "pericardial effusion": 3.21, "pleural effusion": 3.38, "polyneuropathy": 10.92, "product use in unapproved indication": 6.88, "pulmonary oedema": 2.41, "therapeutic response unexpected": 8.29, "tricuspid valve incompetence": 26.95, "urinary tract infection": 2.06, "ventricular hypokinesia": 29.93, "weight decreased": 3.57}